Performance of APLT Applied Therapeutics | 147% in 12m
Compare APLT with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Applied Therapeutics with its related Sector/Index XBI
Performance Duell APLT vs XBI
| TimeFrame | APLT | XBI |
|---|---|---|
| 1 Week | -14.2% | 1.00% |
| 1 Month | -20.5% | 3.39% |
| 3 Months | -7.03% | 5.72% |
| 6 Months | -20.0% | 3.10% |
| 12 Months | 147.0% | 28.65% |
| YTD | 34.3% | 9.92% |
| Rel. Perf. 1m | -2.22 | |
| Rel. Perf. 3m | -0.25 | |
| Rel. Perf. 6m | -3.18 | |
| Rel. Perf. 12m | -3.18 | |
| Spearman 1m | -0.60 | -0.17 |
| Spearman 3m | 0.63 | 0.62 |
Is Applied Therapeutics a good stock to buy?
Probably not. Based on ValueRay Analyses, Applied Therapeutics (NASDAQ:APLT) is currently (September 2024)
not a good stock to buy. It has a ValueRay Growth Rating of -30.29 and therefor a somwhat technical negative rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of APLT as of September 2024 is 5.02. This means that APLT is currently overvalued and has a potential downside of 2.66% (Sold with Premium).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of APLT as of September 2024 is 5.02. This means that APLT is currently overvalued and has a potential downside of 2.66% (Sold with Premium).
Is APLT a buy, sell or hold?
- Strong Buy: 5
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: APLT is performing better - Values below 0%: APLT is underperforming
Compare APLT with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -15.93% | -25.33% | -28.84% | 119.56% |
| US NASDAQ 100 | QQQ | -16.85% | -25.33% | -26.94% | 118.47% |
| US Dow Jones Industrial 30 | DIA | -15.07% | -25.20% | -26.23% | 126.17% |
| German DAX 40 | DBXD | -13.84% | -24.95% | -22.67% | 128.70% |
| UK FTSE 100 | ISFU | -13.42% | -23.65% | -30.84% | 129.34% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -12.37% | -15.98% | -11.27% | 158.51% |
| Hongkong Hang Seng | HSI | -13.77% | -23.67% | -16.84% | 151.89% |
| Japan Nikkei 225 | EXX7 | -15.36% | -26.46% | -16.80% | 133.19% |
| India NIFTY 50 | INDA | -15.12% | -24.24% | -31.71% | 118.96% |
| Brasil Bovespa | EWZ | -11.97% | -19.98% | -12.89% | 149.89% |
APLT Applied Therapeutics vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -14.77% | -22.17% | -27.91% | 118.20% |
| Consumer Discretionary | XLY | -16.37% | -30.59% | -25.84% | 134.80% |
| Consumer Staples | XLP | -14.43% | -26.32% | -31.33% | 127.88% |
| Energy | XLE | -11.93% | -15.21% | -17.21% | 151.37% |
| Financial | XLF | -12.94% | -25.71% | -29.42% | 117.36% |
| Health Care | XLV | -15.09% | -24.79% | -26.76% | 127.17% |
| Industrial | XLI | -15.85% | -25.03% | -26.43% | 121.87% |
| Materials | XLB | -15.11% | -24.68% | -22.49% | 132.26% |
| Real Estate | XLRE | -17.10% | -28.50% | -34.48% | 120.56% |
| Technology | XLK | -18.98% | -26.29% | -24.27% | 116.10% |
| Utilities | XLU | -15.27% | -25.52% | -44.03% | 123.62% |
| Aerospace & Defense | XAR | -15.32% | -24.31% | -30.01% | 115.61% |
| Biotech | XBI | -15.21% | -23.88% | -23.07% | 118.32% |
| Homebuilder | XHB | -17.42% | -28.48% | -30.20% | 99.22% |
| Retail | XRT | -13.71% | -21.41% | -17.98% | 127.32% |
Does Applied Therapeutics outperform its market, is APLT a Sector Leader?
Yes, over the last 12 months Applied Therapeutics (APLT) made 146.97%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months APLT made -7.03%, while XBI made 5.72%.
Yes, over the last 12 months Applied Therapeutics (APLT) made 146.97%, while its related Sector, the SPDR S&P Biotech (XBI) made 28.65%.
Over the last 3 months APLT made -7.03%, while XBI made 5.72%.
| Period | APLT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -20.49% | 3.39% | 4.84% |
| 3 Months | -7.03% | 5.72% | 3.61% |
| 12 Months | 146.97% | 28.65% | 27.41% |